Expertise in
25
conditions

Dr. John A. Belperio

Pulmonary Medicine
The Regents Of The University Of California
757 Westwood Plz, 
Los Angeles, CA 
Offers Telehealth
Expertise in
25
conditions
The Regents Of The University Of California
757 Westwood Plz, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Belperio is a Pulmonary Medicine provider in Los Angeles, California. Dr. Belperio is highly rated in 25 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 142 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Temple University School Of Medicine
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in CA
Hospital Affiliations
Ronald Reagan UCLA Medical Center
Santa Monica - UCLA Med Ctr & Orthopaedic Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
757 Westwood Plz, Los Angeles, CA 90095
Other Locations
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2020 Santa Monica Blvd, Suite 210, Santa Monica, CA 90404
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
900 Weyburn Place, Suite 14 171, Los Angeles, CA 90095

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Enrollment Status: Completed
Publish Date: March 21, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Enrollment Status: Withdrawn
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
Enrollment Status: Withdrawn
Publish Date: September 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
Enrollment Status: Completed
Publish Date: December 17, 2019
Intervention Type: Procedure
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Enrollment Status: Withdrawn
Publish Date: March 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

142 Total Publications

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis.
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis.
Journal: Journal of visualized experiments : JoVE
Published: May 26, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Rajan Saggar
Pulmonary Medicine
Expertise in
14
conditions
Dr. Rajan Saggar
Pulmonary Medicine

The Regents Of The University Of California

900 Weyburn Place, Suite 14 171, 
Los Angeles, CA 
 (0.4 mi)
310-825-8173
Languages Spoken:
English
Offers Telehealth

Rajan Saggar is a Pulmonary Medicine provider in Los Angeles, California. Dr. Saggar is highly rated in 14 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Thrombectomy.

Expertise in
19
conditions
Dr. Toby M. Maher
Pulmonary Medicine
Expertise in
19
conditions
Dr. Toby M. Maher
Pulmonary Medicine

USC Care Medical Group Inc

1520 San Pablo St, 
Los Angeles, CA 
 (13.9 mi)
800-872-2273
Languages Spoken:
English
Offers Telehealth

Toby Maher is a Pulmonary Medicine provider in Los Angeles, California. Dr. Maher is highly rated in 19 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Tissue Biopsy.

Expertise in
10
conditions
Dr. Paul W. Noble
Pulmonary Medicine | Intensive Care Medicine
Expertise in
10
conditions
Dr. Paul W. Noble
Pulmonary Medicine | Intensive Care Medicine

Cedars-Sinai Medical Center

8723 Alden Dr, 
Los Angeles, CA 
 (3.7 mi)
310-423-5000
Experience:
41+ years
Languages Spoken:
English
Offers Telehealth

Paul Noble is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Los Angeles, California. Dr. Noble has been practicing medicine for over 41 years is highly rated in 10 conditions, according to our data. His top areas of expertise are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Belperio's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 12 Advanced Conditions
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile